Metabolomics -- studying metabolites and other chemicals produced by the body and its bacteria -- is one of the fastest growing biomedical niches. Jeremy Nicholson, a leader in the field, said metabolomics could improve drug discovery for the variety of conditions that gut microbes influence, from liver diseases to Crohn's disease and irritable bowel syndrome.

Related Summaries